Euroscreen S.A. license agreement
Our Intellectual Property lawyers advised Euroscreen, S.A. in the license of technology and compounds to Ortho-McNeil-Janssen Pharmaceuticals,Inc. Euroscreen is a private Belgian, preclinical-stage company that engages in drug discovery and development of small molecule drugs for unmet medical needs including inflammation, metabolism and sex hormone modulation.
Posted on January 7, 2011
RELATED PROFESSIONALS
RELATED SERVICES
INDUSTRIES
Disclaimer
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.